Diastolic Dysfunction Clinical Trials
2 recruiting trials for Diastolic Dysfunction. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Diastolic Dysfunction clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Necmettin Erbakan University (1), Odense University Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Homocysteine Measurement and Echocardiography (diagnostic_test, 1 trial), followed by Aortic valve replacement.
Track Diastolic Dysfunction trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension
This prospective single-center observational study aims to evaluate the relationship between elevated plasma homocysteine levels and early echocardiographic abnormalities in...
Danish National Randomized Study on Early Aortic Valve Replacement in Patients With Asymptomatic Severe Aortic Stenosis
The purpose of this study is to examine the impact of early surgery in patients with asymptomatic severe aortic valve stenosis with signs of subclinical LV dysfunction despite...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Diastolic Dysfunction, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Diastolic Dysfunction, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Diastolic Dysfunction, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.